S&P 500   3,962.56 (+0.73%)
DOW   33,818.21 (+0.66%)
QQQ   283.61 (+1.10%)
AAPL   142.79 (+1.31%)
MSFT   247.19 (+1.15%)
META   116.24 (+2.03%)
GOOGL   94.21 (-0.77%)
AMZN   89.69 (+1.39%)
TSLA   170.59 (-1.98%)
NVDA   167.38 (+3.83%)
NIO   13.23 (+5.17%)
BABA   93.37 (+5.71%)
AMD   70.48 (+0.48%)
T   19.15 (-0.78%)
MU   55.26 (+2.68%)
CGC   3.16 (-2.47%)
F   13.15 (+0.38%)
GE   83.74 (-1.48%)
DIS   92.74 (+0.64%)
AMC   6.25 (+3.31%)
PYPL   75.09 (+0.90%)
PFE   50.98 (+1.47%)
NFLX   307.44 (-0.32%)
S&P 500   3,962.56 (+0.73%)
DOW   33,818.21 (+0.66%)
QQQ   283.61 (+1.10%)
AAPL   142.79 (+1.31%)
MSFT   247.19 (+1.15%)
META   116.24 (+2.03%)
GOOGL   94.21 (-0.77%)
AMZN   89.69 (+1.39%)
TSLA   170.59 (-1.98%)
NVDA   167.38 (+3.83%)
NIO   13.23 (+5.17%)
BABA   93.37 (+5.71%)
AMD   70.48 (+0.48%)
T   19.15 (-0.78%)
MU   55.26 (+2.68%)
CGC   3.16 (-2.47%)
F   13.15 (+0.38%)
GE   83.74 (-1.48%)
DIS   92.74 (+0.64%)
AMC   6.25 (+3.31%)
PYPL   75.09 (+0.90%)
PFE   50.98 (+1.47%)
NFLX   307.44 (-0.32%)
S&P 500   3,962.56 (+0.73%)
DOW   33,818.21 (+0.66%)
QQQ   283.61 (+1.10%)
AAPL   142.79 (+1.31%)
MSFT   247.19 (+1.15%)
META   116.24 (+2.03%)
GOOGL   94.21 (-0.77%)
AMZN   89.69 (+1.39%)
TSLA   170.59 (-1.98%)
NVDA   167.38 (+3.83%)
NIO   13.23 (+5.17%)
BABA   93.37 (+5.71%)
AMD   70.48 (+0.48%)
T   19.15 (-0.78%)
MU   55.26 (+2.68%)
CGC   3.16 (-2.47%)
F   13.15 (+0.38%)
GE   83.74 (-1.48%)
DIS   92.74 (+0.64%)
AMC   6.25 (+3.31%)
PYPL   75.09 (+0.90%)
PFE   50.98 (+1.47%)
NFLX   307.44 (-0.32%)
S&P 500   3,962.56 (+0.73%)
DOW   33,818.21 (+0.66%)
QQQ   283.61 (+1.10%)
AAPL   142.79 (+1.31%)
MSFT   247.19 (+1.15%)
META   116.24 (+2.03%)
GOOGL   94.21 (-0.77%)
AMZN   89.69 (+1.39%)
TSLA   170.59 (-1.98%)
NVDA   167.38 (+3.83%)
NIO   13.23 (+5.17%)
BABA   93.37 (+5.71%)
AMD   70.48 (+0.48%)
T   19.15 (-0.78%)
MU   55.26 (+2.68%)
CGC   3.16 (-2.47%)
F   13.15 (+0.38%)
GE   83.74 (-1.48%)
DIS   92.74 (+0.64%)
AMC   6.25 (+3.31%)
PYPL   75.09 (+0.90%)
PFE   50.98 (+1.47%)
NFLX   307.44 (-0.32%)
NASDAQ:ALGN

Align Technology - ALGN Stock Forecast, Price & News

$189.91
+2.58 (+1.38%)
(As of 12/8/2022 11:46 AM ET)
Add
Compare
Today's Range
$186.44
$192.20
50-Day Range
$174.58
$229.91
52-Week Range
$172.05
$688.60
Volume
12,676 shs
Average Volume
894,609 shs
Market Capitalization
$14.83 billion
P/E Ratio
29.35
Dividend Yield
N/A
Price Target
$298.00

Align Technology MarketRank™ Forecast

Analyst Rating
Moderate Buy
2.75 Rating Score
Upside/​Downside
59.8% Upside
$298.00 Price Target
Short Interest
Healthy
3.45% of Float Sold Short
Dividend Strength
N/A
Sustainability
-1.34
Upright™ Environmental Score
News Sentiment
1.14mentions of Align Technology in the last 14 days
Based on 4 Articles This Week
Insider Trading
Acquiring Shares
$2.20 M Bought Last Quarter
Proj. Earnings Growth
15.15%
From $5.81 to $6.69 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

3.13 out of 5 stars

Medical Sector

5th out of 1,027 stocks

Surgical Appliances & Supplies Industry

2nd out of 24 stocks

ALGN stock logo

About Align Technology (NASDAQ:ALGN) Stock

Align Technology, Inc., a medical device company, designs, manufactures, and markets Invisalign clear aligners and iTero intraoral scanners and services for orthodontists and general practitioner dentists, and restorative and aesthetic dentistry. It operates in two segments, Clear Aligner; and Scanners and Services. The Clear Aligner segment consists of comprehensive products, including Invisalign comprehensive treatment that addresses the orthodontic needs of teenage patients, such as mandibular advancement, compliance indicators, and compensation for tooth eruption; and Invisalign First Phase I and Invisalign First Comprehensive Phase 2 package for younger patients generally between the ages of seven and ten years, which is a mixture of primary/baby and permanent teeth. This segment's non-comprehensive products comprise Invisalign moderate, lite and express packages, and Invisalign go; and non-case products include retention products, Invisalign training fees, and sales of ancillary products, such as cleaning material, and adjusting tools used by dental professionals during the course of treatment. The Scanners and Services segment offers iTero scanner, a single hardware platform with software options for restorative or orthodontic procedures; restorative software for general practitioner dentists, prosthodontists, periodontists, and oral surgeons; and software for orthodontists for digital records storage, orthodontic diagnosis, and for the fabrication of printed models and retainers. This segment also provides computer-aided design and computer-aided manufacturing services; ancillary products, such as disposable sleeves for the wand; iTero model and dies; third party scanners and digital scans; Invisalign outcome simulator, a chair-side and cloud-based application for the iTero scanner; Invisalign progress assessment tool; and TimeLapse technology, which allows doctors or practitioners to compare a patient's historic 3D scans to the present-day scan. The company sells its products in the United States, Switzerland, China, and internationally. Align Technology, Inc. was incorporated in 1997 and is headquartered in Tempe, Arizona.

Receive ALGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Align Technology and its competitors with MarketBeat's FREE daily newsletter.

ALGN Stock News Headlines

MMSI vs. ALGN: Which Stock Is the Better Value Option?
ALGN vs. ROKU: Two 2023 Turnaround Stocks for Courageous Contrarians
Align Technology: Not Aligned
Bear of the Day: Align Technology, Inc. (ALGN)
Align Technology Inc. Q3 Profit Decreases, misses estimates
9 Analysts Have This to Say About Align Tech
2 No-Brainer Buys in This Bear Market
See More Headlines
Receive ALGN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Align Technology and its competitors with MarketBeat's FREE daily newsletter.

ALGN Company Calendar

Last Earnings
10/26/2022
Today
12/08/2022
Fiscal Year End
12/31/2022
Next Earnings (Estimated)
2/01/2023

Industry, Sector and Symbol

Industry
Surgical appliances & supplies
Sub-Industry
Health Care Supplies
Sector
Medical
Current Symbol
NASDAQ:ALGN
CUSIP
01625510
Employees
22,540
Year Founded
1997

Price Target and Rating

Average Stock Price Forecast
$298.00
High Stock Price Forecast
$418.00
Low Stock Price Forecast
$165.00
Forecasted Upside/Downside
+56.9%
Consensus Rating
Moderate Buy
Rating Score (0-4)
2.75
Research Coverage
8 Analysts

Profitability

Net Income
$772.02 million
Pretax Margin
18.21%

Debt

Sales & Book Value

Annual Sales
$3.95 billion
Cash Flow
$11.40 per share
Book Value
$45.94 per share

Miscellaneous

Free Float
77,612,000
Market Cap
$14.83 billion
Optionable
Optionable
Beta
1.65

Social Links


Key Executives

  • Mr. Joseph M. HoganMr. Joseph M. Hogan (Age 65)
    Pres, CEO & Director
  • Mr. John F. MoriciMr. John F. Morici (Age 55)
    CFO & Exec. VP of Global Fin.
  • Mr. Emory M. WrightMr. Emory M. Wright (Age 52)
    Exec. VP of Global Operations
    Comp: $1.35M
  • Ms. Julie Ann ColettiMs. Julie Ann Coletti (Age 53)
    Exec. VP and Chief Legal & Regulatory Officer
    Comp: $1.37M
  • Mr. Stuart HockridgeMr. Stuart Hockridge (Age 50)
    Exec. VP of Global HR
    Comp: $1.3M
  • Mr. Zelko RelicMr. Zelko Relic (Age 57)
    Exec. VP & CTO
  • Ms. Shirley Stacy
    VP of Corp. Communications & Investor Relations
  • Mr. Vamsi Mohan-Raj Pudipeddi (Age 50)
    Exec. VP, Chief Product & Marketing Officer and MD of Asia Pacific
  • Mr. Simon BeardMr. Simon Beard (Age 55)
    MD for Americas Region & Exec. VP
  • Ms. Jennifer Olson-Wilk (Age 44)
    Exec. VP of Customer Success













ALGN Stock - Frequently Asked Questions

Should I buy or sell Align Technology stock right now?

8 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Align Technology in the last year. There are currently 1 sell rating and 7 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" ALGN shares.
View ALGN analyst ratings
or view top-rated stocks.

What is Align Technology's stock price forecast for 2023?

8 brokerages have issued 1-year price targets for Align Technology's stock. Their ALGN share price forecasts range from $165.00 to $418.00. On average, they anticipate the company's stock price to reach $298.00 in the next year. This suggests a possible upside of 59.1% from the stock's current price.
View analysts price targets for ALGN
or view top-rated stocks among Wall Street analysts.

How have ALGN shares performed in 2022?

Align Technology's stock was trading at $657.18 on January 1st, 2022. Since then, ALGN shares have decreased by 71.5% and is now trading at $187.33.
View the best growth stocks for 2022 here
.

Are investors shorting Align Technology?

Align Technology saw a decrease in short interest in the month of November. As of November 15th, there was short interest totaling 2,520,000 shares, a decrease of 9.0% from the October 31st total of 2,770,000 shares. Based on an average daily trading volume, of 1,020,000 shares, the days-to-cover ratio is presently 2.5 days. Approximately 3.5% of the company's stock are short sold.
View Align Technology's Short Interest
.

When is Align Technology's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, February 1st 2023.
View our ALGN earnings forecast
.

How were Align Technology's earnings last quarter?

Align Technology, Inc. (NASDAQ:ALGN) released its quarterly earnings data on Wednesday, October, 26th. The medical equipment provider reported $0.98 earnings per share for the quarter, missing the consensus estimate of $1.93 by $0.95. The medical equipment provider had revenue of $890.35 million for the quarter, compared to analysts' expectations of $973 million. Align Technology had a trailing twelve-month return on equity of 14.39% and a net margin of 13.22%. The business's revenue for the quarter was down 12.4% on a year-over-year basis. During the same period last year, the firm posted $2.28 EPS.
Read the conference call transcript
.

What is Joe Hogan's approval rating as Align Technology's CEO?

346 employees have rated Align Technology Chief Executive Officer Joe Hogan on Glassdoor.com. Joe Hogan has an approval rating of 97% among the company's employees. This puts Joe Hogan in the top 30% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Align Technology own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Align Technology investors own include NVIDIA (NVDA), Netflix (NFLX), Alibaba Group (BABA), PayPal (PYPL), Micron Technology (MU), Adobe (ADBE), Visa (V), Salesforce (CRM), Mastercard (MA) and Tesla (TSLA).

What is Align Technology's stock symbol?

Align Technology trades on the NASDAQ under the ticker symbol "ALGN."

Who are Align Technology's major shareholders?

Align Technology's stock is owned by a variety of retail and institutional investors. Top institutional investors include Vanguard Group Inc. (10.51%), Edgewood Management LLC (4.96%), State Street Corp (3.86%), Sands Capital Management LLC (2.96%), Polen Capital Management LLC (2.55%) and Price T Rowe Associates Inc. MD (2.37%). Insiders that own company stock include Andrea Lynn Saia, C Raymond Larkin Jr, C Raymond Larkin, Jr, Emory Wright, George J Morrow, John Morici, Joseph Lacob, Joseph M Hogan, Julie Ann Coletti, Julie Tay, Kevin C Burns, Robert E Fitzgerald, Simon Beard, Stuart A Hockridge, Stuart A Hockridge, Susan E Siegel, Thomas M Prescott, Vamsi Mohan Raj Pudipeddi, Warren S Thaler, Yuval Shaked and Zelko Relic.
View institutional ownership trends
.

How do I buy shares of Align Technology?

Shares of ALGN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Align Technology's stock price today?

One share of ALGN stock can currently be purchased for approximately $187.33.

How much money does Align Technology make?

Align Technology (NASDAQ:ALGN) has a market capitalization of $14.63 billion and generates $3.95 billion in revenue each year. The medical equipment provider earns $772.02 million in net income (profit) each year or $6.47 on an earnings per share basis.

How many employees does Align Technology have?

The company employs 22,540 workers across the globe.

Does Align Technology have any subsidiaries?
The following companies are subsidiares of Align Technology: Align Technology Switzerland GmbH, Cadent, G.L. Dental Couture, and exocad Global Holdings GmbH (“exocad”).
Read More
How can I contact Align Technology?

Align Technology's mailing address is 2820 ORCHARD PARKWAY, SAN JOSE CA, 95134. The official website for the company is www.aligntech.com. The medical equipment provider can be reached via phone at (408) 470-1000, via email at align@ethoscommunication.com, or via fax at 408-470-1010.

This page (NASDAQ:ALGN) was last updated on 12/8/2022 by MarketBeat.com Staff